Adverse drug events are a leading cause of hospitalization, disability, and death, all at great human and financial cost. The elderly are particularly vulnerable, as aging affects our ability to process medications and our resistance to adverse effects. They are likely to be on multiple medications for various chronic conditions putting them most at risk, which can cause cognitive difficulties and affect balance.
TaperMD is a software platform offering a web-based clinical decision support system and clinical monitoring pathway. It provides prescribers with tools and resources integrated with a proven methodology to manage, communicate and review patient medication plans. Its focus is to reduce the medication burden in older adults in a systematic and holistic manner. TaperMD was developed through research at McMaster University in Canada.
TaperMD Trial in Marlborough
We are currently trialing TaperMD for patients aged over 75 years old in an aged residential rest home setting who are being prescribed 5 or more prescription drugs. In 2022, the trial will be extended to patients living in our community.
Resources for the trial & standard operating procedures can be accessed below:
If you are a GP or Pharmacist interested in joining the programme then please contact firstname.lastname@example.org – we will send through SOP’s relative to your role.